lobbying_activities: 2513433

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2513433	94de2575-68bb-45ae-98e4-84e304d87783	Q3	MCDERMOTT WILL & SCHULTE LLP	24338	SURESCRIPTS	2020	third_quarter	MMM	Efforts to advance interoperability and to ensure technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services benefits in a timely way, including improving the process for updating the SCRIPT electronic prescribing standard to allow for both testing and for more expeditious adoption of updated electronic prescribing standards. Efforts to ensure timely implementation of the SUPPORT Act requirement for electronic prescribing of controlled substances in the Medicare Part D program beginning January 1, 2021. Efforts to support CMSs proposed adoption of NCPDP SCRIPT Standard Version 2017071 for secure electronic prior authorization transactions for Part D-covered drugs and to ensure that problematic preamble language in the proposed rule is addressed so that electronic prior authorization by non-Part D prescription drug plans is not impeded by the final rule.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE	60000		0	0	2020-10-18T11:41:36.327000-04:00